BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12805411)

  • 1. Thyrotropin-releasing hormone receptor processing: role of ubiquitination and proteasomal degradation.
    Cook LB; Zhu CC; Hinkle PM
    Mol Endocrinol; 2003 Sep; 17(9):1777-91. PubMed ID: 12805411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization of the thyrotropin-releasing hormone receptor and its ligand during endocytosis and recycling.
    Ashworth R; Yu R; Nelson EJ; Dermer S; Gershengorn MC; Hinkle PM
    Proc Natl Acad Sci U S A; 1995 Jan; 92(2):512-6. PubMed ID: 7831321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of follitropin receptor cell surface residency by the ubiquitin-proteasome pathway.
    Cohen BD; Bariteau JT; Magenis LM; Dias JA
    Endocrinology; 2003 Oct; 144(10):4393-402. PubMed ID: 12960054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the thyrotropin-releasing hormone receptor and its ligand are recycled dissociated from each other.
    Petrou CP; Tashjian AH
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):107-13. PubMed ID: 7864795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A receptor-G protein coupling-independent step in the internalization of the thyrotropin-releasing hormone receptor.
    Petrou C; Chen L; Tashjian AH
    J Biol Chem; 1997 Jan; 272(4):2326-33. PubMed ID: 8999941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-dependent and -independent proteasomal degradation of apoB associated with endoplasmic reticulum and Golgi apparatus, respectively, in HepG2 cells.
    Liao W; Chang BH; Mancini M; Chan L
    J Cell Biochem; 2003 Aug; 89(5):1019-29. PubMed ID: 12874835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin-proteasome pathway regulates the availability of the GH receptor.
    van Kerkhof P; Smeets M; Strous GJ
    Endocrinology; 2002 Apr; 143(4):1243-52. PubMed ID: 11897680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage of the ubiquitin-conjugating system and the endocytic pathway in ligand-induced internalization of the growth hormone receptor.
    Govers R; van Kerkhof P; Schwartz AL; Strous GJ
    EMBO J; 1997 Aug; 16(16):4851-8. PubMed ID: 9305627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate of internalized thyrotropin-releasing hormone receptors monitored with a timer fusion protein.
    Cook LB; Hinkle PM
    Endocrinology; 2004 Jul; 145(7):3095-100. PubMed ID: 15117874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of an antiserum which recognizes the native receptor for thyrotropin-releasing hormone.
    Chen F; Selinger Z; Marks P; Belinsky G; Tashjian AH
    Biochem Biophys Res Commun; 2001 Jul; 285(3):742-50. PubMed ID: 11453656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable ubiquitination of human T-cell leukemia virus type 1 tax is required for proteasome binding.
    Chiari E; Lamsoul I; Lodewick J; Chopin C; Bex F; Pique C
    J Virol; 2004 Nov; 78(21):11823-32. PubMed ID: 15479824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
    Sheaff RJ; Singer JD; Swanger J; Smitherman M; Roberts JM; Clurman BE
    Mol Cell; 2000 Feb; 5(2):403-10. PubMed ID: 10882081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gap junction protein connexin43 is degraded via the ubiquitin proteasome pathway.
    Laing JG; Beyer EC
    J Biol Chem; 1995 Nov; 270(44):26399-403. PubMed ID: 7592854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin-dependent regulation of the synapse.
    DiAntonio A; Hicke L
    Annu Rev Neurosci; 2004; 27():223-46. PubMed ID: 15217332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [TRH receptor].
    Yamada M; Mori M
    Nihon Rinsho; 1998 Jul; 56(7):1931-7. PubMed ID: 9702078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin-proteasome pathway regulates lysosomal degradation of the growth hormone receptor and its ligand.
    van Kerkhof P; Strous GJ
    Biochem Soc Trans; 2001 Aug; 29(Pt 4):488-93. PubMed ID: 11498015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel transcript for the thyrotropin-releasing hormone receptor in human pituitary and pituitary tumors.
    Yamada M; Hashimoto K; Satoh T; Shibusawa N; Kohga H; Ozawa Y; Yamada S; Mori M
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4224-8. PubMed ID: 9398744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells.
    Huan JY; Streicher JM; Bleyle LA; Koop DR
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):332-43. PubMed ID: 15364548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of bile salt-dependent lipase secretion in AR4-2J rat pancreatic cells induces its degradation by the proteasome.
    Le Petit-Thevenin J; Verine A; Nganga A; Nobili O; Lombardo D; Bruneau N
    Biochim Biophys Acta; 2001 Feb; 1530(2-3):184-98. PubMed ID: 11239821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor regulates ubiquitination, internalization and proteasome-dependent degradation of connexin43.
    Leithe E; Rivedal E
    J Cell Sci; 2004 Mar; 117(Pt 7):1211-20. PubMed ID: 14970263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.